Which has grown faster, AVAH or RXRX?

Over the past five years, RXRX grew revenue faster — AVAH at a 9.65% CAGR versus RXRX at 45.50%.

Is AVAH or RXRX more profitable?

AVAH runs the higher net margin — AVAH at 10.56% versus RXRX at -945.92%.

How have AVAH and RXRX total returns compared?

Over the past 5 years, AVAH delivered 9.75% and RXRX delivered -25.86% annualized total return. Past performance doesn't predict future results.

Aveanna Healthcare Holdings Inc. (AVAH) vs Recursion Pharmaceuticals, Inc. (RXRX)

A side-by-side comparison of Aveanna Healthcare Holdings Inc. and Recursion Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AVAH

Aveanna Healthcare Holdings Inc.

$2.72B

$12.49HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

RXRX

Recursion Pharmaceuticals, Inc.

$2.48B

$4.72HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT

Total return — AVAH vs RXRX

growth of $100 · dividends reinvested · last 5y

AVAH +3.1% (+0.6%/yr)RXRX -84.8% (-31.4%/yr)AVAH compounded faster over this window

Log scale — wide-divergence pair

AVAH RXRX

AVAH vs RXRX: by the numbers

•AVAH is the larger company ($2.72B vs $2.48B market cap).
•AVAH is profitable (10.56% net margin) while RXRX runs a net loss (-945.92%).
•RXRX grew revenue faster over the past five years (45.50% vs 9.65% CAGR).

Metrics side by side

Valuation

Metric	AVAH	RXRX
P/E ratio	9.88	N/A
Forward P/E	15.16	N/A
P/S ratio	1.04	45.16
P/B ratio	9.46	2.71
EV / EBITDA	13.32	N/A
FCF yield	5.83%	N/A

Profitability

Metric	AVAH	RXRX
Gross margin	31.95%	-61.96%
Operating margin	11.12%	-867.87%
Net margin	10.56%	-945.92%
ROE	95.64%	-56.71%
ROIC	15.45%	-49.78%

Growth (annualized)

Metric	AVAH	RXRX
Revenue CAGR (5Y)	9.65%	45.50%
FCF CAGR (5Y)	58.99%	N/A
Total return CAGR (5Y)	9.75%	-25.86%

Frequently asked

Which has grown faster, AVAH or RXRX?: Over the past five years, RXRX grew revenue faster — AVAH at a 9.65% CAGR versus RXRX at 45.50%.
Is AVAH or RXRX more profitable?: AVAH runs the higher net margin — AVAH at 10.56% versus RXRX at -945.92%.
How have AVAH and RXRX total returns compared?: Over the past 5 years, AVAH delivered 9.75% and RXRX delivered -25.86% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AVAH analysis Full RXRX analysis Interactive comparison tool

Dig into the metrics

Aveanna Healthcare P/E ratio Aveanna Healthcare ROE Recursion Pharmaceuticals ROE Aveanna Healthcare operating margin Recursion Pharmaceuticals operating margin Aveanna Healthcare revenue growth Recursion Pharmaceuticals revenue growth Aveanna Healthcare free cash flow Recursion Pharmaceuticals free cash flow

Aveanna Healthcare & Recursion Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.